用于妇科癌症术后放疗女性的EPIC肠道和泌尿域扩展验证
本研究在278例接受盆腔放疗的子宫内膜癌或宫颈癌术后女性中,对EPIC肠道和泌尿域进行扩展验证,评估其敏感性、信度和同时效度。结果显示治疗期间肠道和泌尿评分显著变差且组间有差异,各时间点信度可接受至良好(基线一处除外),域内功能与困扰评分相关性一致强于跨域相关,肠道域与PRO-CTCAE相关性在治疗期间强于与FACT的相关性。结论认为EPIC肠道和泌尿域是有效、可靠且敏感的患者报告结局测量工具。
要点
- EPIC肠道和泌尿域在278例妇科癌症术后盆腔放疗女性中显示有效、可靠且敏感。
- 治疗期间肠道和泌尿平均评分显著变差,且组间存在差异。
- 域内功能与困扰评分相关性一致强于跨域相关,支持概念区分度。
核心结论
- EPIC肠道和泌尿域测量的是健康的概念上离散的组成部分,是接受盆腔放疗女性中有效、可靠且敏感的患者报告结局测量工具。
研究设计与样本
- 在NRG Oncology/RTOG 1203研究中,对278例接受盆腔放疗的子宫内膜癌或宫颈癌术后女性,在治疗前、治疗期间和治疗后完成EPIC肠道域、EPIC泌尿域、PRO-CTCAE肠道毒性和FACT生活质量评估,并评估敏感性、信度和同时效度。
主要发现
- 278例入组女性的肠道和泌尿平均评分在治疗期间显著变差,且组间存在差异。
- 肠道和泌尿域评分在所有时间点均获得可接受至良好的信度,基线一处除外。
- 肠道和泌尿域内功能与困扰评分之间的相关性一致强于跨域相关性。
- 治疗期间肠道域评分与PRO-CTCAE的相关性强于与FACT的相关性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Women with endometrial or cervical cancer at risk for recurrence receive postoperative radiation therapy (RT). A patient reported outcomes (PRO) instrument to assess bowel and urinary toxicities is the Expanded Prostate Cancer Index Composite (EPIC), which has been validated in men with prostate cancer. As this instrument specifically measures bowel toxicity and the degree to which this is a problem, it was used in NRG Oncology/RTOG 1203 to compare intensity modulated RT (IMRT) to standard RT. This paper reports on the expanded validation of EPIC for use in women receiving pelvic RT. METHODS: In addition to the EPIC bowel domain, urinary toxicity (EPIC urinary domain), patient reported bowel toxicities (PRO-CTCAE) and quality of life (Functional Assessment of Cancer Therapy (FACT)) were completed before, during and after treatment. Sensitivity, reliability and concurrent validity were assessed. RESULTS: Mean bowel and urinary scores among 278 women enrolled were significantly worse during treatment and differed between groups. Acceptable to good reliability for bowel and urinary domain scores were obtained at all time points with the exception of one at baseline. Correlations between function and bother scores within the bowel and urinary domains were consistently stronger than those across domains. Correlations between bowel domain scores and PRO-CTCAE during treatment were stronger than those with the FACT. CONCLUSION: Correlations within and among the instruments indicate EPIC bowel and urinary domains are measuring conceptually discrete components of health. These EPIC domains are valid, reliable and sensitive instruments to measure PRO among women undergoing pelvic radiation.
引用
- Gil KM, Pugh SL, Klopp AH, et al. Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy. Gynecol Oncol. 2019. PMID: 31104905. doi:10.1016/j.ygyno.2019.04.682
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。